You receive an envelope — or a notification in your patient portal — and inside is a table of numbers. Most of them have a small tick or the word "normal" next to them. You feel briefly reassured, perhaps a little confused, and then file it away. Sound familiar?
This experience is almost universal. And it represents one of the largest missed opportunities in preventive medicine. Blood results, when properly interpreted, are not a pass-or-fail sheet — they are a detailed biological map. Reading them correctly requires understanding not just whether a number falls inside a range, but what that range was designed to capture in the first place.
This article gives you the tools to read that map. We will cover how a German laboratory report is structured, why "normal" ranges are built on a statistical convention rather than a health ideal, and which specific biomarkers — with both standard and longevity-optimised reference points — every patient should understand. All ranges discussed reflect values commonly used in longevity medicine practice; they are not diagnostic criteria and must always be interpreted in full clinical context by a qualified physician.
Reading a German lab report: what the columns mean
German laboratory reports follow a consistent format, whether they come from Synlab, MVZ Berlin, or your local Direktlabor. Once you understand the column structure, the document becomes far less intimidating. Here is what you will typically see:
The marker being measured. Also called "Parameter."
The laboratory's reference range. Often population-derived.
The unit of measurement (%, mg/L, nmol/L, etc.).
Your actual result. A flag (↑ ↓ H L) means outside the reference range.
The column you should look at most carefully: Messwert
The Messwert (or Ergebnis — "result") is your actual measured value. Most patients focus only on whether a flag appears next to it. This is understandable but insufficient. A result can sit comfortably inside the Referenzbereich and still be far from optimal for long-term health.
The Referenzbereich (reference range) is the interval within which approximately 95% of a "healthy" reference population falls. This sounds reassuring — until you ask: who was in that reference population? In most cases, it is a general adult population that includes people who are sedentary, metabolically unhealthy, and not selected for exceptional longevity. Being in the same range as the average of that group is a floor, not a ceiling.
The Einheit (unit) matters for cross-referencing values between different labs and countries. Germany and most of Europe use SI units (nmol/L, µmol/L, mg/L), while the United States frequently uses conventional units (ng/mL, µg/dL). If you compare your results against international longevity literature, always confirm which unit system is being used before drawing any conclusions.
Normal vs optimal: a critical distinction
The single most important concept in understanding blood results is the difference between a population-normal range and a longevity-optimised range. Confusing the two is the source of most false reassurance in preventive medicine.
A population-normal range is a statistical construct. It is derived by measuring a marker in a large group of adults, taking the central 95% of results, and calling that interval "normal." By mathematical definition, 2.5% of perfectly healthy individuals will fall above this range and 2.5% below it — not because something is wrong with them, but because they sit at the statistical tails of a distribution.
More importantly, the people who define these ranges are not selected for longevity. They are representative of the general adult population in a given country — which in Germany, as in most Western nations, includes a high prevalence of overweight, insulin resistance, subclinical inflammation, and metabolic syndrome. Being "normal" by this standard means being similar to a population that is itself not optimally healthy.
Longevity medicine takes a different approach. Rather than asking "where does the average person fall?", it asks: "what values are associated with the lowest risk of cardiovascular disease, cancer, neurodegeneration, and metabolic decline over a 20-to-40-year horizon?" The answer to that question produces different ranges — often substantially tighter — which are commonly used in longevity medicine to guide clinical decisions. These are not arbitrary or fringe targets; they are grounded in large prospective cohort studies, mechanistic research, and the clinical experience of physicians specialising in healthspan extension.
A useful analogy: Imagine "normal blood pressure" were defined by measuring 10,000 randomly selected adults. Given that roughly a third of adults have hypertension, the resulting "normal range" would include readings we now recognise as clinically elevated. This is, in essence, what happens with many biochemical reference ranges. The range describes the population — it does not define health.
Key biomarkers every patient should understand
The following seven biomarkers are among the most clinically significant from a longevity medicine perspective. For each, I have listed the standard laboratory reference range (as commonly used in German labs) alongside the range commonly targeted in longevity medicine practice. These longevity-optimised values reflect current clinical consensus in the field — they are not diagnostic thresholds and should be interpreted by a physician in the context of your full clinical picture.
| Biomarker | Standard Normal Range | Longevity-Optimised Range | Why It Matters |
|---|---|---|---|
| HbA1c | < 5.7% | < 5.2% | Average blood glucose over ~90 days. Elevations above 5.2% are commonly associated in longevity medicine with early insulin resistance, increased glycation, and cardiovascular risk — years before diabetes diagnosis. |
| Fasting Insulin | Rarely ordered; varies widely | < 6 µIU/mL | Perhaps the most underused marker in standard practice. Elevated fasting insulin — even with a normal HbA1c — is an early signal of metabolic dysfunction. Standard labs often do not include this test without a specific physician request. |
| ApoB | < 130 mg/dL | < 80 mg/dL | Apolipoprotein B measures the number of atherogenic particles in circulation — a more accurate predictor of cardiovascular risk than LDL-cholesterol alone. In high-risk individuals, longevity physicians commonly target values below 70 mg/dL. Standard panels frequently omit ApoB entirely. |
| hs-CRP | < 5 mg/L | < 1 mg/L | High-sensitivity C-reactive protein is a marker of systemic inflammation. Values between 1 and 5 mg/L — technically "normal" — are associated in large cohort studies with meaningfully increased cardiovascular and metabolic risk. Longevity medicine targets the lowest achievable level. |
| TSH | 0.4 – 4.0 mIU/L | 1.0 – 2.0 mIU/L | Thyroid-stimulating hormone. A TSH of 3.8 is "normal" by population standards but is commonly associated with fatigue, cognitive slowing, and weight resistance — particularly in women over 35. Longevity medicine practitioners typically seek a narrower window in the lower-to-mid normal range, supported by Free T3 and Free T4 values. |
| Vitamin D (25-OH) | > 50 nmol/L | 100 – 150 nmol/L | Vitamin D functions more as a hormone than a vitamin, influencing immune regulation, bone metabolism, cardiovascular function, and mood. The standard threshold of 50 nmol/L represents sufficiency to prevent severe deficiency disease (rickets, osteomalacia) — not the level associated with optimal immune and metabolic function. |
| Ferritin (women) |
12 – 150 µg/L | 50 – 100 µg/L | Ferritin reflects iron storage. A result of 14 µg/L sits inside the standard range — but at this level, many women experience fatigue, hair thinning, impaired cognitive function, and poor exercise tolerance. Longevity-oriented practice targets a value sufficient to support neurological and mitochondrial function. Ferritin above 200 µg/L in women also warrants investigation. |
Medical disclaimer: All ranges listed above reflect values commonly used in longevity medicine practice and are provided for educational purposes only. They are not diagnostic criteria, treatment targets, or medical advice. Blood results must always be interpreted in full clinical context by a qualified physician — individual factors including age, sex, comorbidities, medications, and symptom picture significantly affect how any single value should be understood.
What "within range" does not mean
The phrase "within range" has a specific and limited meaning: your result falls within the central 95% of a reference population. Nothing more. It does not mean:
- That your result is optimal for your age, sex, or health goals
- That it will still be within range in two years at the same trajectory
- That it is not contributing to symptoms you are currently experiencing
- That it has been interpreted in the context of your other results
- That the reference population used reflects healthy, high-functioning individuals
This matters enormously in practice. Consider a patient in their early 40s with persistent fatigue, difficulty maintaining weight, and low motivation. Their standard blood panel returns all values within range. They are told everything is normal. But their HbA1c is 5.5% (standard normal: below 5.7%), their fasting insulin — if ordered — might be 14 µIU/mL, their TSH is 3.4, their ferritin is 18 µg/L, and their hs-CRP is 2.8 mg/L. Every single one of these results is technically "within range." Every single one, viewed through a longevity medicine lens, is a signal worth addressing.
The cumulative picture is not visible from any single flagged value. It is visible only when results are read together, in clinical context, by someone trained to look for early patterns rather than late-stage disease markers.
Red flags that standard reports often don't highlight
Beyond the individual biomarkers above, there are patterns and omissions in standard blood reports that a longevity-trained physician looks for specifically — and that a routine report will rarely flag.
Markers that are frequently not ordered at all
Fasting insulin is the clearest example. Insulin resistance is the central metabolic dysfunction underlying type 2 diabetes, cardiovascular disease, non-alcoholic fatty liver disease, and polycystic ovary syndrome — yet fasting insulin is almost never included in a standard blood panel. HbA1c alone misses the early phase of insulin resistance, when insulin is elevated but glucose is still normal. By the time HbA1c begins to rise, the problem has typically been developing for years.
Apolipoprotein B (ApoB) is another. LDL-cholesterol, which appears on virtually every standard panel, is a calculated estimate of cholesterol concentration. ApoB directly measures the number of atherogenic lipoprotein particles — a far more accurate predictor of plaque progression and cardiovascular risk. Multiple cardiovascular guidelines now recommend ApoB as the primary lipid metric, yet it remains routinely absent from standard panels in Germany.
Lipoprotein(a) — Lp(a) is genetically determined, present in roughly 20% of the population at high levels, and dramatically increases cardiovascular risk. It is not treatable with standard lifestyle interventions, but knowing your level informs the aggressiveness with which other cardiovascular risk factors should be managed. It is rarely ordered without a specific physician request.
Results that trend in the wrong direction — but haven't crossed the line yet
Standard reports are binary: inside or outside the reference range. They provide no information about trajectory. An HbA1c that has moved from 4.8% to 5.1% to 5.4% over three years is still technically normal — but it represents a clear directional signal that warrants intervention now, not when it crosses 5.7%.
This is why longitudinal tracking matters as much as individual snapshots. A single blood result tells you where you are today. A series of results tells you where you are going.
Results within range but contextually significant
A TSH of 3.8 in a woman reporting fatigue, hair loss, and low mood is clinically significant even if it is technically within the 0.4–4.0 range. A Free T3 at the lower quartile of the normal range, in the same patient, with a slightly elevated TSH, tells a coherent physiological story. Each value alone is "normal"; together, they constitute a thyroid function picture worth addressing.
This is precisely what is missed when results are reviewed in isolation by a system designed to flag out-of-range values rather than identify suboptimal patterns.
When to interpret results yourself — and when to get a physician
There is real value in understanding your own blood results. Being an informed patient improves the quality of clinical conversations, helps you track changes over time, and allows you to ask better questions. The information in this article is intended to support that understanding.
Self-interpretation, however, has clear limits — and recognising those limits is itself a form of health literacy.
You can reasonably do yourself:
- Compare your Messwert to the Referenzbereich and note any flagged values
- Cross-reference values against the longevity-optimised ranges discussed in this article as a starting point for informed conversation
- Track the same markers over time to identify trends
- Note which important markers were not ordered on your panel
Where physician interpretation is essential:
- Any result that is flagged outside the reference range — particularly cardiac, thyroid, haematological, or liver markers
- Results that are within range but contextually inconsistent with your symptoms
- Interpreting patterns across multiple markers simultaneously
- Deciding whether a particular finding warrants further investigation or intervention
- Adjusting medications, hormones, or supplementation based on results
- Any result you are concerned about, regardless of whether it is flagged
The risk of unguided self-interpretation is not that people learn too much — it is that partial knowledge without clinical context leads either to unnecessary anxiety about normal variation or, more commonly, to false reassurance about findings that warrant attention. A number out of context is not the same as a result properly understood.
A note on HWG compliance: The ranges discussed in this article are provided for educational orientation only. They reflect values commonly used in longevity medicine and preventive care, not universally agreed diagnostic or treatment thresholds. What constitutes an appropriate target for any individual depends on their complete clinical picture — age, sex, family history, medications, lifestyle, and the full constellation of biomarkers — and should be determined in consultation with a qualified physician.
The Lab Interpretation service: clinical depth without waiting months for a specialist
The gap between receiving a blood result and having it properly explained is one of the most common frustrations I hear from patients. Standard GP appointments — even private ones — rarely allow the time for a thorough biomarker conversation. Specialist referrals often mean waiting weeks or months. And online searches, while useful for background knowledge, cannot tell you what your specific combination of results means for you specifically.
The longyxhealth Lab Interpretation service (€245) exists precisely to bridge this gap. In a focused 45-minute video consultation, I review your complete blood panel against longevity-optimised reference ranges, explain every result in plain language, identify patterns and omissions that standard reports leave unaddressed, and provide a written summary of findings and next steps.
You bring your results — from any German Direktlabor, your GP, or a previous private specialist — and leave with a clear, physician-level understanding of what they mean. No intake forms to complete first, no requirement to commit to a longer programme. A single focused consultation designed to answer the question: what do my results actually mean, and what should I do about them?
For patients who want to go further — comprehensive baseline testing, protocol design, and ongoing monitoring — the Lab Interpretation session can serve as the starting point for a full longevity programme. But it stands alone as a complete service for anyone who already has results and wants them properly read.
What the Lab Interpretation session covers: Full review of all provided biomarkers · Comparison against longevity-optimised reference ranges · Identification of missing markers worth adding to your next panel · A written summary of key findings · Clear, prioritised next steps — whether that is lifestyle adjustment, further testing, or specialist referral where indicated. Service provided under §2 GOÄ Honorarvereinbarung. Lab fees for any additional tests are paid directly to the laboratory.
Taking your results seriously — from the right starting point
The goal of this article is not to make you anxious about your blood results. It is to give you a more accurate framework for what they can and cannot tell you — and to make clear that "everything is normal" is not the same as "everything is optimal."
Blutwerte verstehen — understanding your blood values — is increasingly recognised as a fundamental health literacy skill. Patients who understand their biomarkers ask better questions, engage more productively with their physicians, and are better positioned to take meaningful preventive action before problems become diseases.
The population-normal reference range will always be a useful first screen. It catches the outliers — the severe deficiencies, the acute disease markers, the results that need urgent attention. It is doing what it was designed to do. But for the patient who wants to understand not just whether something is wrong today, but what trajectory they are on and how to optimise it, a second layer of interpretation — one calibrated to health rather than mere absence of measurable disease — is not a luxury. It is the logical next step.
If you have blood results you want properly reviewed, the Lab Interpretation service is available now. If you are starting from scratch and want to design a comprehensive baseline panel, the Discovery Call is the right first conversation.